E

Evofem Biosciences Inc
F:1AQ1

Watchlist Manager
Evofem Biosciences Inc
F:1AQ1
Watchlist
Price: 0.1432 EUR -2.59% Market Closed
Market Cap: 65.8m EUR

Intrinsic Value

1AQ1 price has not been updated for more than 8 months. This may indicate that the stock has been delisted.
1AQ1 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of 1AQ1.

The Intrinsic Value is calculated as the average of DCF and Relative values:

1AQ1 Intrinsic Value
Not Available
E
Base Case Scenario
Compare 1AQ1 to

Fundamental Analysis

Evofem Biosciences Inc
F:1AQ1
US
Pharmaceuticals
Market Cap
65.8m EUR
IPO
Nov 20, 2014
US
Pharmaceuticals
Market Cap
65.8m EUR
IPO
Nov 20, 2014
Price
€
$
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Contacts
Loading...
How do you feel about 1AQ1?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Evofem Biosciences Inc

Balance Sheet Decomposition
Evofem Biosciences Inc

Current Assets 6.9m
Receivables 4.3m
Other Current Assets 2.6m
Non-Current Assets 1.3m
PP&E 1.3m
Other Non-Current Assets 35k
Current Liabilities 74.2m
Accounts Payable 16.3m
Accrued Liabilities 7.9m
Other Current Liabilities 50.1m
Non-Current Liabilities 4k
Other Non-Current Liabilities 4k
Efficiency

Free Cash Flow Analysis
Evofem Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Evofem Biosciences Inc

Revenue
16m USD
Cost of Revenue
-5.8m USD
Gross Profit
10.2m USD
Operating Expenses
-27.3m USD
Operating Income
-17.1m USD
Other Expenses
64.6m USD
Net Income
47.5m USD
Fundamental Scores

1AQ1 Profitability Score
Profitability Due Diligence

Evofem Biosciences Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional Net Margin
Strong 3Y Average Net Margin
Exceptional Gross Margin
38/100
Profitability
Score

Evofem Biosciences Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

1AQ1 Solvency Score
Solvency Due Diligence

Evofem Biosciences Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
22/100
Solvency
Score

Evofem Biosciences Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

1AQ1 Price Targets Summary
Evofem Biosciences Inc

There are no price targets for 1AQ1.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Evofem Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for 1AQ1 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y